The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix.
about
Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiationTetranectin Binds to the Kringle 1-4 Form of Angiostatin and Modifies Its Functional ActivityExtracellular matrix as target for antitumor therapyCytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer progression cell lines.Nitroglycerin alters matrix remodeling proteins in THP-1 human macrophages and plasma metalloproteinase activity in rats.Comparative analysis of serum proteomes: Identification of proteins associated with sciatica due to lumbar intervertebral disc herniation.Integrated extracellular matrix signaling in mammary gland development and breast cancer progression.Distribution Patterns of E-Cadherin, Type VII Collagen and Fibronectin in Denture-Related Stomatitis: A Preliminary Study.Epithelial-Mesenchymal Transition Phenotype Is Associated with Clinicopathological Factors That Indicate Aggressive Biological Behavior and Poor Clinical Outcomes in Invasive Breast Cancer.Modeling the mechanics of cancer: effect of changes in cellular and extra-cellular mechanical properties.Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion.Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer.Mammary epithelial cell interactions with fibronectin stimulate epithelial-mesenchymal transitionTenascin-C and fibronectin in normal esophageal mucosa, Barrett's esophagus, dysplasia and adenocarcinoma.Epithelial Mesenchymal Transition (EMT) in Metastatic Breast Cancer in Omani Women.Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells.
P2860
Q24649457-5FA56E96-2C56-4117-B5CF-228D4374B9D2Q24804463-9A696FDF-B30F-4956-BAC7-AD7FD01DC7A3Q28082018-150DCB3B-722E-4CE2-9196-836F14140E2FQ33677510-C6CFD592-91BF-4FF5-90A1-B66A0747F74DQ34574503-35730588-2ACE-40D1-94F3-C299187869CAQ35211461-A459E4B2-44A3-4301-9B7F-A6825ACE3D36Q35300762-845C6EED-6D6F-49C7-A457-9E1F616109F8Q35700975-6452348A-6E7D-4753-B3DE-84A59513585AQ36145725-AA0A1973-57DC-48FE-94F1-351D748316CAQ36917436-7D311086-F221-4201-AFDD-E46E10C974A2Q37438494-CABBE906-A29F-45A3-BEA7-E4E3E485F647Q37457838-7B7D7B81-096E-4414-A864-EFC97CE5C2F9Q37603567-CD369D20-8C31-40C4-93D0-045608F22F57Q42366517-2DC3F63B-C04A-46AE-87B1-DD6AD20DCD87Q42509993-F5EA818D-FA29-4E31-934D-8B42E03A1A79Q54092702-B66A5D3B-DC87-431A-9D18-21A866F5CCAE
P2860
The distribution of fibronectin, laminin and tetranectin in human breast cancer with special attention to the extracellular matrix.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The distribution of fibronecti ...... n to the extracellular matrix.
@ast
The distribution of fibronecti ...... n to the extracellular matrix.
@en
type
label
The distribution of fibronecti ...... n to the extracellular matrix.
@ast
The distribution of fibronecti ...... n to the extracellular matrix.
@en
prefLabel
The distribution of fibronecti ...... n to the extracellular matrix.
@ast
The distribution of fibronecti ...... n to the extracellular matrix.
@en
P1433
P1476
The distribution of fibronecti ...... n to the extracellular matrix.
@en
P2093
Christensen L
P577
1992-01-01T00:00:00Z